D B Hunninghake

Therapeutic response to lovasatain (Mevinolin) in nonfamilial hypercholesterolemia - A Multicenter study

D B Hunninghake, Joanie Larose, Robert H. Palmer et al. · JAMA · 1986 · 175 citations

Metabolic Syndrome, Thrombosis, Lipid Disorder +14

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial

Peter M. Jones, D B Hunninghake, Keith C. Ferdinand et al. · Clinical Therapeutics · 2004 · 113 citations

Lipid Ratios, Cardiovascular Disease, Stellar Trial +5

Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.

Byron J. Hoogwerf, Abdelkarim Waness, Michael D. Cressman et al. · Diabetes · 1999 · 86 citations

Treating to meet NCEP-recommended LDL cholesterol concentrations with atorvastatin, fluvastatin, lovastatin, or simvastatin in patients with risk factors for coronary heart disease.

D B Hunninghake, Rebecca G. Bakker-Arkema, J P Wigand et al. · PubMed · 1998 · 71 citations

Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.

Rita A. Halpin, E H Ulm, A. E. Till et al. · Drug Metabolism and Disposition · 1993 · 54 citations